Skip to content

Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents

Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02395003
Enrollment
26
Registered
2015-03-20
Start date
2016-04-30
Completion date
2023-03-07
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Obesity

Keywords

Obesity, Pediatric

Brief summary

Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2 diabetes. The present studies will focus on determining what might cause fat to accumulate in the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to develop in obese adolescents.

Detailed description

The purpose of this study is to test whether the reduced transcription of key lipogenic/adipogenic genes in abdominal subcutaneous adipose tissue (SAT) in obese adolescents with a High VAT/SAT (visceral adipose tissue/subcutaneous adipose tissue) ratio translates functionally into a reduced in vivo triglyceride (TG) synthesis and adipocyte proliferation, which in turn will contribute to ectopic fat accumulation and insulin resistance (IR). To test whether the storage capacity of gluteal SAT is linked to the level of VAT/SAT fat distribution in obese adolescents. To explore if changes in dietary fat intake (palmitate intake) alters ceramide concentration in both plasma and adipose tissue (AT) and the Inflammasome complex in the different fat distribution phenotypes and their associations with IR.

Interventions

OTHERPalmitate Diet

Subject with high VAT/SAT ratio will be randomized to a high or low palmitate oil diet.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Overweight (85-95th% age and gender specific) or Obese (\>95th% age and gender specific) * Ages 12-18 years * Absence of any endocrinopathy * Absence of any therapy with medication known to alter glucose metabolism (i.e.: Oral steroids, certain psychiatric medications such as Xeleca, Lithium, Paxil) * English Speaking subjects

Exclusion criteria

* Any disease known to alter glucose metabolism (T2DM) * Diuretic Medication * Pregnant or breastfeeding * Type 1 or 2 diabetes

Design outcomes

Primary

MeasureTime frameDescription
Fat BiopsiesBaseline1\) To test whether the reduced transcription of key lipogenic/adipogenic genes in abd SAT in obese adolescents with a High VAT/SAT ratio translates functionally into a reduced in vivo TG synthesis and adipocyte proliferation, which in turn will contribute to ectopic fat accumulation and IR.

Secondary

MeasureTime frameDescription
MRIBaselineVisceral to Subcutaneous fat storage ratio

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026